Allosteric Regulation of Phosphofructokinase-1 in a Muscle Biopsy
A muscle biopsy is studied in vitro with saturating substrate. Phosphofructokinase-1 (PFK-1) activity is measured under four conditions: (A) pH 7.4, 1 mM ATP, 0.1 mM fructose-6-phosphate (F6P); (B) pH 7.4, 5 mM ATP, 0.1 mM F6P; (C) pH 7.1, 5 mM ATP, 0.1 mM F6P; (D) pH 7.1, 5 mM ATP, 0.1 mM F6P plus 2 mM AMP and 0.5 mM fructose-2,6-bisphosphate. Activity in A is 100 (arbitrary units). Activity in B is 20; in C is 8; in D is 85. The biopsy also shows elevated citrate (2 mM) and low insulin signaling. The enzyme is a tetramer that displays cooperativity with respect to F6P.
1. Interpret the changes from A to B to C using the allosteric properties of PFK-1, and explain why pH matters.
Read the worked answer
PFK-1 is allosterically inhibited by ATP and citrate and activated by AMP, ADP, and fructose-2,6-bisphosphate; it shows positive cooperativity for F6P (sigmoidal kinetics). Going from 1 mM to 5 mM ATP (A→B) shifts the enzyme toward the T state, raising the apparent K0.5 for F6P and dropping activity from 100 to 20 at the same subsaturating F6P-this is allosteric ATP inhibition, distinct from ATP's role as substrate. Lowering pH to 7.1 (B→C, activity 8) protonates key residues (notably a histidine involved in tetramer stabilization and F6P binding), further stabilizing the T state and reducing activity; acidosis during fatigue therefore amplifies ATP inhibition. Judgment: the drop is not substrate depletion-F6P is held constant-it is a shift in the allosteric equilibrium.
2. Condition D restores activity to 85 despite high ATP and low pH. What does this reveal about the relative potency of the activators, and how would elevated citrate modify the prediction?
Read the worked answer
AMP and fructose-2,6-bisphosphate together largely overcome ATP and proton inhibition, shifting the tetramer toward the R state and lowering K0.5 for F6P. Fructose-2,6-bisphosphate is the most potent activator (it both increases affinity for F6P and relieves ATP inhibition); AMP signals low energy charge and reinforces this. That activity reaches 85 (not 100) shows activation is partial-high ATP and low pH still exert inhibitory pressure, so the activators compete with inhibitors rather than abolishing them. Elevated citrate (2 mM) is an additional allosteric inhibitor that would lower the D value below 85, especially since citrate reinforces ATP inhibition; low insulin signaling would reduce fructose-2,6-bisphosphate production (via PFK-2), so the in vivo activator tone is likely weaker than in the cuvette. Judgment: the in vitro D result overestimates glycolytic flux in the intact biopsy.